Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01181453 | Pivotal Trial of Dermagraft(R) to Treat Diabetic Foot Ulcers | PHASE3 | COMPLETED | 314 | — | — | Dec 1, 1998 | Mar 1, 2000 | May 20, 2018 | - | — |
| NCT01181440 | Dermagraft(R) for the Treatment of Patients With Diabetic Foot Ulcers | PHASE3 | COMPLETED | 281 | — | — | Sep 1, 1994 | Jan 1, 1997 | May 20, 2018 | - | — |
| Name | Type | Description |
|---|---|---|
| Dermagraft | DEVICE | Weekly application of Dermagraft(R) with standard care |
| Comparator | OTHER | Weekly application of standard care |
| Dermagraft(R) | DEVICE | Weekly application of Dermagraft(R) with conventional care |
| Conventional care | OTHER | Weekly application of conventional care |